E-LIB Suche - Ergebnisse für: Granger, Victoire

1

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

2

Safety and feasibility of chemotherapy followed by liver tr..:

Adam, René ; Badrudin, David ; Chiche, Laurence...
eClinicalMedicine. 72 (2024) - p. 102608 , 2024

Link: https://doi.org/10.1016/..

3

Withholding the Introduction of Anti-Epidermal Growth Facto..:

Palmieri, Lola-Jade ; Mineur, Laurent ; Tougeron, David...
The Oncologist. 25 (2019) 2 - p. e266-e275 , 2019

Link: https://doi.org/10.1634/..

4

Gastric cancer: French intergroup clinical practice guideli..:

Zaanan, Aziz ; Bouché, Olivier ; Benhaim, Leonor...
Digestive and Liver Disease. 50 (2018) 8 - p. 768-779 , 2018

Link: https://doi.org/10.1016/..

5

Patient-reported tolerance in treatments approved in neuroe..:

Plante, Arnaud ; Baudin, Eric ; Do Cao, Christine...
Clinics and Research in Hepatology and Gastroenterology. 42 (2018) 2 - p. 153-159 , 2018

Link: https://doi.org/10.1016/..

6

Evaluating bevacizumab in combination with FOLFIRI after th..:

Walter, Thomas ; Malka, David ; Hentic, Olivia...
Digestive and Liver Disease. 50 (2018) 2 - p. 195-198 , 2018

Link: https://doi.org/10.1016/..

7

Initial endoscopic description of esophageal squamous cell ..:

Granger, Victoire ; Assenat, Eric ; Barbotte, Eric...
Gastroentérologie Clinique et Biologique. 30 (2006) 12 - p. 1365-1370 , 2006

Link: https://doi.org/10.1016/..

8

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

9

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

10

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

11

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

12

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

13

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

14

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...

15

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
info:eu-repo/semantics/altIdentifier/doi/10.1093/oncolo/oyae079. , 2024

Link: https://univ-rennes.hal...